Henry Schein, Inc. (HSIC), based in Melville, New York, is a global leader in healthcare product distribution, serving the ...

Henry Schein, Inc. (HSIC) stock saw a modest uptick, ending the day at $73.22 which represents a slight increase of $1.47 or 2.05% from the prior close of $71.75. The stock opened at $72.23 and ...

The Acentus transaction follows Henry Schein’s acquisition of Prism Medical Products, LLC in 2021 and Shield Healthcare and ...

Evercore ISI analyst Elizabeth Anderson CFA maintained a Hold rating on Henry Schein (HSIC – Research Report) yesterday and set a price target ...

Valued at a market cap of $8.8 billion, Henry Schein, Inc. (HSIC) provides healthcare products and services to dental ...

Provident Healthcare Partners ("Provident"), a leading healthcare investment banking firm, announced it has advised Acentus ...

This was the stock's second consecutive day of losses.

Shares of Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report) have been assigned an average recommendation of “Moderate Buy” ...

BofA sees 2025 challenges for healthcare tech and distributors but upgrades Cardinal Health and Henry Schein, highlighting ...

Tampa, Florida-based Acentus, a national medical supplier, specializes in the delivery of continuous glucose monitors (CGMs).